Last edition
News about "FYB206"
FYB206 Becomes First Keytruda Biosimilar to Get US FDA Review
The US FDA has accepted FYB206’s Biologics License Application (BLA) for review, marking the first publicly announced Keytruda biosimilar filing acceptance.
FYB206 | 13/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members